The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $28.06

Today's change-0.11 -0.39%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.
 

Wright Medical Group NV

Nasdaq: WMGI
Last

(U.S.) $28.06

Today's change-0.11 -0.39%
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Wright Medical Group NV down (U.S.)$0.11

Wright Medical Group NV closed lower Friday, dropping (U.S.)$0.11 or 0.39% to (U.S.)$28.06. Over the last five days, shares have gained 4.08% and are currently 1.75% off of the 52-week high. Shares have outperformed the S&P 500 by 35.77% during the last year.

Key company metrics

  • Open(U.S.) $28.06
  • Previous close(U.S.) $28.17
  • High(U.S.) $28.14
  • Low(U.S.) $27.65
  • Bid / Ask-- / --
  • YTD % change+22.11%
  • Volume1,037,255
  • Average volume (10-day)1,300,165
  • Average volume (1-month)869,723
  • Average volume (3-month)848,707
  • 52-week range(U.S.) $15.52 to (U.S.) $28.56
  • Beta1.06
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.60
Updated February 24 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-23.89%

Wright Medical Group NV has a net profit margin of -23.89%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.57%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 25, 201609/25/2016Jun 26, 201606/26/2016Mar 27, 201603/27/2016Dec 27, 201512/27/2015
Revenue157171169169
Total other revenue--------
Total revenue157171169169
Gross profit111122123105
Total cost of revenue46494764
Total operating expense196205200340
Selling / general / administrative130136135255
Research & development12121223
Depreciation / amortization7765
Interest expense (income), net operating--------
Unusual expense (income)-------7
Other operating expenses, total--------
Operating income-39-34-31-171
Interest income (expense), net non-operating-17-13-12-37
Gain (loss) on sale of assets--------
Other--------
Income before tax-55-45-41-219
Income after tax-53-42-40-213
Income tax, total-2-3-1-6
Net income-110-229-48-273
Total adjustments to net income--------
Net income before extra. items-53-42-40-213
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-53-42-40-213
Inc. avail. to common incl. extra. items-110-229-48-273
Diluted net income-110-229-48-273
Dilution adjustment0------
Diluted weighted average shares103103103112
Diluted EPS excluding extraordinary itemsvalue per share-0.51-0.41-0.39-1.90
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.51-0.41-0.39-1.94